Literature DB >> 28617879

It is time to rethink H. pylori therapy.

Bich N Dang1, David Y Graham2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28617879      PMCID： PMC6905079          DOI： 10.15403/jgld.2014.1121.262.hpy

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN： 1841-8724            Impact factor:   2.008


× No keyword cloud information.
  10 in total

Review 1.  How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.

Authors:  David Y Graham; Sun-Young Lee
Journal:  Gastroenterol Clin North Am       Date:  2015-06-19       Impact factor: 3.806

2.  Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe.

Authors:  Agostino Di Ciaula; Giuseppe Scaccianoce; Marino Venerito; Angelo Zullo; Leonilde Bonfrate; Theodore Rokkas; Piero Portincasa
Journal:  J Gastrointestin Liver Dis       Date:  2017-06       Impact factor: 2.008

3.  Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection.

Authors:  William M Geisler; Apurva Uniyal; Jeannette Y Lee; Shelly Y Lensing; Shacondra Johnson; Raymond C W Perry; Carmel M Kadrnka; Peter R Kerndt
Journal:  N Engl J Med       Date:  2015-12-24       Impact factor: 91.245

4.  Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

Authors:  Bich N Dang; David Y Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-03       Impact factor: 46.802

Review 5.  Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.

Authors:  Akiko Shiotani; Hong Lu; Maria Pina Dore; David Y Graham
Journal:  Cleve Clin J Med       Date:  2017-04       Impact factor: 2.321

6.  High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.

Authors:  A Zullo; L Gatta; V De Francesco; C Hassan; C Ricci; V Bernabucci; M Cavina; E Ierardi; S Morini; D Vaira
Journal:  Aliment Pharmacol Ther       Date:  2005-06-15       Impact factor: 8.171

7.  Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy.

Authors:  P Della Monica; A Lavagna; G Masoero; L Lombardo; L Crocellá; A Pera
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

Review 8.  Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.

Authors:  Julia Kirchheiner; Silke Glatt; Uwe Fuhr; Ulrich Klotz; Ingolf Meineke; Thomas Seufferlein; Jürgen Brockmöller
Journal:  Eur J Clin Pharmacol       Date:  2008-10-17       Impact factor: 2.953

Review 9.  Role of bismuth in improving Helicobacter pylori eradication with triple therapy.

Authors:  Maria Pina Dore; Hong Lu; David Y Graham
Journal:  Gut       Date:  2016-02-04       Impact factor: 23.059

Review 10.  Helicobacter pylori therapy: a paradigm shift.

Authors:  David Y Graham; Maria Pina Dore
Journal:  Expert Rev Anti Infect Ther       Date:  2016-05-03       Impact factor: 5.091
  10 in total
  1 in total

1.  Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.

Authors:  David Y Graham; Hong Lu; Maria Pina Dore
Journal:  Helicobacter       Date:  2018-11-15       Impact factor: 5.753
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.